Sort   by:  
 Page size 
UnknownSurgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis.
Not available
S-EPMC8268293 | biostudies-literature
UnknownCyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer.
Not available
S-EPMC5594254 | biostudies-literature
UnknownArgininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.
Not available
S-EPMC4415574 | biostudies-literature
UnknownSelecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations.
Not available
S-EPMC3688691 | biostudies-literature
UnknownMulticentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study.
Not available
S-EPMC7540301 | biostudies-literature
UnknownLiposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study.
Not available
S-EPMC8606735 | biostudies-literature
UnknownNo association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol.
Not available
S-EPMC8282609 | biostudies-literature
UnknownReal-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer.
Not available
S-EPMC9954707 | biostudies-literature
UnknownDosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study.
Not available
S-EPMC9256928 | biostudies-literature
UnknownGermline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
Not available
S-EPMC10865564 | biostudies-literature
Sort   by:  
 Page size